联环药业现多路资金博弈 知名营业部现分歧交易

Group 1 - Lianhuan Pharmaceutical's trading volume exceeded 20%, leading to its appearance on the stock market's "Dragon and Tiger List" [1] - The top five buying seats included Guotai Junan Securities Headquarters with 42.78 million yuan, followed by招商证券 Shenzhen Hongling Road and UBS Shanghai Pudong with 16.72 million yuan and 16.38 million yuan respectively, totaling 105 million yuan in buying [1] - Guotai Junan Securities Headquarters and UBS Shanghai Pudong both appeared on the buying and selling lists, indicating a significant divergence in market sentiment [1] Group 2 - The largest seller was Guotai Junan Securities Shanghai Songjiang with 51.84 million yuan, while China International Capital Corporation Beijing Jianguomen Outer Street ranked third with 17.62 million yuan, totaling 131 million yuan in selling [1] - Historical data shows that in the last three months, the probability of stocks rising three days after being listed by招商证券 Shenzhen Hongling Road and中泰证券 Guangdong was 50%, while it was only 26.53% for China International Capital Corporation Beijing Jianguomen Outer Street [2] - The stock has been listed four times in the last three months, with significant price volatility during this period [2]